Faculty Opinions Recommendation of Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia

    March 2012 in “ Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ”
    Abraham Zlotogorski, Yuval Ramot
    Image of study
    TLDR Hair loss can be an early sign of prostate enlargement.
    This document discusses a study that examined the association between androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). Previous studies had already shown a link between these two conditions, but they mainly focused on older populations with existing BPH. In this study, the researchers evaluated a younger population of AGA patients before the onset of urinary symptoms. They used objective measures such as ultrasound and urinary flowmetry to assess urinary symptoms. The study found that AGA patients had higher prostate volume, lower urinary flow, and higher prostate-specific antigen (PSA) values compared to normal controls, confirming the association between AGA and BPH. The authors suggest that dermatologists should monitor AGA patients for the development of urinary symptoms. However, further confirmation and larger studies are needed to validate these findings.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community 1 month of using fin, so happy

      in Progress Pictures  862 upvotes 4 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Why does finasteride stop working?

      in Finasteride/Dutasteride  26 upvotes 2 months ago
      Finasteride may seem less effective over time due to increased DHT sensitivity or aging, but it still suppresses DHT. Switching to dutasteride offers stronger DHT suppression but may increase estrogen levels.

    Similar Research

    5 / 1000+ results